Pharmacovigilance of major parmaceutical innovation

Zhongguo Zhongyao Zazhi

Volumn 36, Issue 20, 2011, Pages 2831-2835

  Xiang, Yongyang ^a   Xie, Yanming ^b   Yi, Danhui ^c  

^a RENMIN UNIVERSITY OF CHINA   (China)

^b INSTITUTE OF CHINESE MATERIA MEDICA   (China)

^c NONE

Author keywords

Data mining; Pharmacovigilance

Indexed keywords

CHINESE DRUG;

ARTICLE; CHINESE MEDICINE; DATA BASE; DRUG MONITORING; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; FOOD AND DRUG ADMINISTRATION; FRUSTRATION; GOLD STANDARD; INFORMATION TECHNOLOGY; MEDICAL RESEARCH; NETHERLANDS; REGISTRATION; SIGNAL DETECTION; STATISTICAL ANALYSIS; UNITED KINGDOM;

DATA MINING; HUMANS; MEDICINE, CHINESE TRADITIONAL; PHARMACOVIGILANCE; PRODUCT SURVEILLANCE, POSTMARKETING;

EID: 84855714611     PISSN: 10015302     EISSN: None     Source Type: Journal    
DOI: 10.4268/cjcmm20112020     Document Type: Article

References (8)

1. Meyboom R H B, Egberts A C G, Gribnau F W J, et al. Pharmacor vigilance in perspective[J]. Drug Saf, 1999,21:429.
2. Manfred Hauben, Lester Reich, Charles M Gerrits. Comparative performance of proportional reporting ratios (PRR) and multi-item Gamma Poisson shrinker (MGPS) for the identification of crystalluria and urinary tract calculi caused by drugs [J]. Pharmacoepidemiol Drug Saf, 2005,14(S1/S218):S7.
3. Hand D J, Blunt G, Kelly M, et al. Data mining for fun and profit [J]. Stat Sci, 2000,15:111.
4. Hauben M. Application of an empiric Bayesian data mining algorithm to reports of pancreatitis associated with atypical antipsychotics[J]. Pharmacotherapy, 2004,24(9):1122.
5. Follmann M, Michel A, Geyer C. Comparison of different methods for signal detection in the drug safety database of a pharmaceutical company[C]. Bordeaux: Poster presentation at 20th ICPE conference, 2004.